FDA NDC Directory · JSON-LD · Markdown

PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND

NDC 0517-4300 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Generic namePaclitaxel
Labeler / ManufacturerAmerican Regent, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211875
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS
Active ingredientsPACLITAXEL (100 mg/20mL)
Marketing started20230502
Package count1

External sources

Source: openFDA. Public-domain (CC0).